title: How do estrogens control lymphoma?
abstract: In this issue of Blood, Yakimchuk and colleagues show that estrogen receptor β (ERβ) signaling can act tumor-suppressive predominantly through the regulation of genes by ERβ in the tumor, not in the microenvironment, and point out new therapeutic strategies.
authors.affiliation: SAARLAND UNIVERSITY MEDICAL SCHOOL.
authors.forename: Klaus
authors.initials: K
authors.lastname: Roemer
authors.forename: Klaus
authors.initials: K
authors.lastname: Römer
authors.forename: Michael
authors.initials: M
authors.lastname: Pfreundschuh
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D047629:Estrogen Receptor beta / Q000819:agonists*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D009570:Nitriles / Q000627:therapeutic use*; D011422:Propionates / Q000627:therapeutic use*
chemical_list: C486182:2,3-bis(4-hydroxyphenyl)-propionitrile; D020533:Angiogenesis Inhibitors; D047629:Estrogen Receptor beta; D009570:Nitriles; D011422:Propionates